Filing Flows

Filing Flows › Medline (MDLN) › Who owns the stock

Who owns Medline (MDLN) stock

380 funds reported Medline (MDLN) shares in their latest 13F filings, worth $31.5B in all. The largest holder is Carlyle Group ($7.4B). Last quarter 292 funds added to their stakes and 133 cut them.

Largest holders of MDLN (13F)Largest holders of MDLN (13F)Carlyle Group$7.4BBlackstone$4.0BFMR LLC$1.9BCapital Research Global Investors$1.6BInvesco$1.5BBlackRock$1.0BMorgan Stanley$852MLone Pine Capital LLC$827MVanguard Group$793MMassachusetts Financial Services$787M

Largest holders (13F)

FundSharesValueChangeQuarter
Carlyle Group187,083,713$7.4Bunchanged2026-06-30
Blackstone101,791,008$4.0Bdecrease2026-06-30
FMR LLC46,963,203$1.9Bincrease2026-06-30
Capital Research Global Investors39,963,790$1.6Bincrease2026-06-30
Invesco38,346,937$1.5Bincrease2026-06-30
BlackRock26,393,587$1.0Bincrease2026-06-30
Morgan Stanley21,605,662$852Mincrease2026-06-30
Lone Pine Capital LLC20,968,367$827Mincrease2026-06-30
Vanguard Group18,887,568$793Mnew2025-12-31
Massachusetts Financial Services19,888,806$787Mincrease2026-06-30
Vanguard Capital Management LLC17,816,057$703Mincrease2026-06-30
Vanguard Portfolio Management LLC16,781,031$662Mincrease2026-06-30
Jupiter Topco LLC15,858,400$625Mbase2026-06-30
Janus Henderson Group11,451,861$507Mincrease2026-03-31
DZ Bank AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main11,956,905$472Mincrease2026-06-30

Medline's latest quarter

Medline, Q3 2026: revenue $7.9B (+10% year over year), operating margin 6.4%, net earnings $198M, operating cash flow $1.0B. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most MDLN stock?

By the latest 13F filings: Carlyle Group ($7.4B); Blackstone ($4.0B); FMR LLC ($1.9B); Capital Research Global Investors ($1.6B); Invesco ($1.5B).

What is the short interest in MDLN?

40,816,957 shares were sold short at the 2026-10-15 settlement, -22.53% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.